Literature DB >> 3711026

Rapid tranquilization: a comparison of thiothixene with loxapine.

W R Dubin, K J Weiss.   

Abstract

This 6-day study evaluated the efficacy of equivalent doses of loxapine and thiothixene for rapid tranquilization of acutely disturbed, psychotic patients. After initial tranquilization with intramuscular injections for 24 hours, 58 patients were treated for 5 days with oral medication. With both drugs, intramuscular treatment demonstrated clinically significant improvement from baseline on Clinical Global Impressions and Brief Psychiatric Rating scales; this improvement continued during the oral phase. Median time to tranquilization was significantly less with loxapine (60 minutes) than with thiothixene (95 minutes); during the oral phase, there were no significant differences between the two treatment groups. Side effects were minimal during the intramuscular phase; dystonia was most common during the oral phase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711026

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.

Authors:  Nicholas Gross; Leon S Greos; Eli O Meltzer; Selwyn Spangenthal; Robert S Fishman; Daniel A Spyker; James V Cassella
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-12       Impact factor: 2.849

Review 2.  Loxapine for schizophrenia.

Authors:  A Chakrabarti; A Bagnall; P Chue; M Fenton; V Palaniswamy; W Wong; J Xia
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 3.  Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.

Authors:  G V Milton; M W Jann
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

Review 4.  [Psychopharmacotherapy in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-11       Impact factor: 0.840

5.  Revisiting loxapine: a systematic review.

Authors:  Dina Popovic; Philippe Nuss; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2015-04-01       Impact factor: 3.455

6.  Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.

Authors:  Daniel A Spyker; Robert A Riesenberg; James V Cassella
Journal:  J Clin Pharmacol       Date:  2015-05-06       Impact factor: 3.126

7.  Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.

Authors:  Daniel A Spyker; James V Cassella; Randall R Stoltz; Paul P Yeung
Journal:  Pharmacol Res Perspect       Date:  2015-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.